F8 and hemophilia A: If based on patients attending clinics for investigation or treatment of bleeding or bruising, as then found to have low levels of FVIII activity consistent with hemophilia A, this would approximate around 1 in 5000 of the population (or 0.02%) for developed countries [12,13], with most patients being male (given that the affected gene is the X-chromosome).